AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
Migrate infobox: document_type -> document_category; add specific form as document_type
 
(2 intermediate revisions by the same user not shown)
Line 4:
| period = FY
| period_label = FY25
| document_typedocument_category = Analyst presentation
| publication_date = 2026-02-26
| language = English
Line 18:
=== Full Year 2025 earnings presentation ===
 
* '''Presentation title''':AXA Full Year 2025'' earnings presentation delivered on February Earnings26, Presentation2026 <sup>p. 1</sup>
* '''Presentation date''': February 26, 2026 <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* '''Disclaimer'Forward-looking statements'' regardinginclude forward-lookingpredictions, statementstrends, whichplans, areexpectations, subjector toobjectives knownbased andon unknownManagement's riskscurrent views and uncertaintiessubject to change <sup>p. 2</sup>.
* '''Expected UEPS growth''' for 2026 is provided as one-off guidance in the context of the lastfinal year of the Group's current strategic plan <sup>p. 2</sup>.
* '''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document for the year ended December 31, 2024 <sup>p. 2</sup>.
* '''Non-GAAPAlternative performance measures''' and alternative performance measures (APMs) used include "Underlyingunderlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure <sup>p. 2</sup>.
* ''Financial statements status'': AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p. 3, 4</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 3, 9</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p. 3, 13</sup>
 
== FY25 Highlights ==
 
* '''Section 1divider slide for ''': FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
 
=== Full Year 2025 | Excellent performance ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-sm" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
| class="col-s" style="text-align:right" | +6% vs. FY24
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| class="col-s" style="text-align:right" | +8% vs. FY24
|-
| style="text-align:left" | Return on equity
| class="col-s" style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| class="col-s" style="text-align:right" | 224%
|-
| style="text-align:left" | DividendDPS per sharegrowth
| class="col-s" style="text-align:right" | +8% growth
|-
| style="text-align:left" | ShareAnnual share buyback
| class="col-s" style="text-align:right" | EUR 1.25bn annual program
|-
| style="text-align:left" | Underlying EPS growth targetoutlook for 2026
| class="col-s" style="text-align:right" | Upper end of 6% to -8% target range
|}
</div>
* '''Dividend per share''' +8% growth,proposal based on the dividend proposed by AXA's Board of Directors' recommendation on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting approval on April 30, 2026 <sup>p. 5</sup>
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
 
=== Executing the plan on growth, margin and efficiency ===
Line 79 ⟶ 80:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at (constant FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
Line 89 ⟶ 90:
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
 
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup>
* Scaling the business: Continued investments in growth and technology
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence
* Scaling the business: Continued investments in growth and technology <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 grossGross written premium split (FY25, excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 110:
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|}
</div>
 
* ''Secular trends'' fuelingfuel demand across businesses, driven includeby protection gaps and emerging corporate risks, alongsideas well as demographics driving demand for private retirement and healthcare <sup>p. 7</sup>.
* ''Our right to win'' is supported by four keystrategic pillars:
** Leading brand & high customer NPS <sup>p. 7</sup>
** Strong and diversified distribution <sup>p. 7</sup>
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
 
=== Laying the foundation for the next plan ===
 
* '''Strategic pillars''' established to lay the foundation for the next plan <sup>p. 8</sup>:
** ''Clear tech'' and AI roadmap <sup>p. 8</sup>
** ''Driving efficiency'' across operations <sup>p. 8</sup>
** ''Enhancing capital'' allocation discipline <sup>p. 8</sup>
** ''Building resilience'' across the business <sup>p. 8</sup>
* '''Earnings growth'' outlook''' supported by thesestrong pillarsfoundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
 
== Business Performance ==
Line 140:
=== FY25 business performance ===
 
* '''Section 2''': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
=== Strong delivery across our businesses ===
 
* '''Premium growth basis''': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* '''Earnings growth basis''': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* '''Total GWP definition''': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ BusinessGross performancewritten premiums and underlying earnings by region FY25 <sup>p. 10</sup>
! style="text-align:left" | Region (share of total GWP¹)
! class="col-m" style="text-align:right" | Gross written premiums
! class="col-m" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 31bn
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
Line 175:
=== P&C | Strong margins, confidence in sustaining growth ===
 
* '''Gross written premiums''' (GWP) totalreached EUR 58bn, including AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>.
* (donut) '''GWP mix''': Retail, AXA XL (Large & Specialty), SME & Mid-market — shares not labeled <sup>p. 11</sup>.
** '''UnderlyingAXA earnings'''XL +9%GWP atincludes constantAXA FXXL toRe premiums of EUR 52.9bn6bn <sup>p. 11</sup>.
* ''Underlying earnings'' +9% at constant FX to EUR 5.9bn <sup>p. 11</sup>.
* '''Retail and SME & Mid-market strategy''':
* ''Retail and SME & Mid-market'' strategic outlook:
** '''2025''': Growing volumes while expanding margins <sup>p. 11</sup>.
** '''Beyond 2025''': InvestingGrowing tovolumes improve customer retention andwhile expanding distribution footprintmargins <sup>p. 11</sup>.
** ''Beyond 2025'': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
* '''AXA XL (Large & Specialty) strategy''':
* ''AXA XL (Large & Specialty)'' strategic outlook:
** '''2025''': Profitable growth with stable margins <sup>p. 11</sup>.
** '''Beyond 2025''': Capitalizing on attractiveProfitable growth opportunities and continuedwith cyclestable managementmargins <sup>p. 11</sup>.
** ''Beyond 2025'': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
* '''Earnings drivers''':
* ''Earnings drivers'' supporting performance:
** Continued progress on efficiency <sup>p. 11</sup>.
** Higher investment income <sup>p. 11</sup>.
Line 191 ⟶ 192:
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
<div style="overflow-x:auto">
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
{| class="wikitable fintable"
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
|+ Financial highlights and strategic priorities <sup>p. 12</sup>
* ''Long-term business'' strategic priorities:
! style="text-align:left" | EUR billion
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
! class="col-s" style="text-align:right" | Value
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
|-
* ''Short-term business'' strategic priorities:
| style="text-align:left" | Gross written premiums (GWP)
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
| style="text-align:right" | 57
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
|-
* ''Strategic levers'' for growth and efficiency:
| style="text-align:left" | Underlying earnings
** Focus on cost reduction <sup>p. 12</sup>.
| style="text-align:right" | 3.5
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
|}
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
</div>
* (donut) '''GWP mix''': Short-term and Long-term segments — shares not labeled.
* '''Long-term business''' strategic priorities:
** '''2025''': Accelerating net flows in Savings at attractive margins.
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers.
* '''Short-term business''' strategic priorities:
** '''2025''': Growing technical results while absorbing Mexico VAT impact.
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins.
* '''Operational drivers''' supporting growth and efficiency:
** Focus on cost reduction.
** Increasing penetration of Protection riders in Savings offerings.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health.
* '''Underlying earnings''' +7% at constant FX to EUR 3.5bn <sup>p. 12</sup>.
 
== Financial Performance ==
Line 221 ⟶ 210:
=== FY25 financial performance ===
 
* '''Section 3''': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
Line 227 ⟶ 216:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP and& other revenues by segment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change LFL
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 264 ⟶ 253:
|}
</div>
* '''Commercial lines growth''' driven by continuedContinued pricing momentum and volume growth in Mid-market and SME.
* '''AXA XL Insurance''' focused on growingGrowing in lines of business with attractive margins while remaining focused on retention. at AXA XL Insurance
* '''AXA XL Reinsurance''' growthGrowth supported by alternative capital.
* '''Retail lines growth''' supported by favorableFavorable pricing trends and strong growth in net new contracts of (+1.7m in FY25.)
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 273 ⟶ 262:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio componentsbridge, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | Combined ratio
! class="col-s" style="text-align:right" | FY24
Line 303 ⟶ 292:
|}
</div>
* BetterUndiscounted undiscounted current yearCY loss ratio excluding(ex Nat Cat) drivenimproved byfrom:
** Margin expansion in '''Commercial lines''' SME & mid-market business and '''Personal lines''' reflecting favorable pricing environment
** Stable '''AXA XL Insurance''' margins at attractive levels reflecting disciplined cycle management
* ImprovementExpense inratio '''expense ratio'''improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* '''Nat Cat charges''' below normalized load
* Lower reliance on '''priorPrior year reserve development''' shows lower reliance
* TakingReserve prudence enhanced by taking advantage of a good year to enhance '''reserve prudence'''
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 344 ⟶ 333:
|}
</div>
* Underlying earnings grew +9% at constant FX to EUR 5,872m (FY24: EUR 5,510m) <sup>p. 16</sup>.
* Underwriting result (includesimproved expenses)from driven bystrong volume growth (+EURand 292m)improved andall-year margincombined improvementratio (+EURwhile 189m)enhancing <sup>p.reserve 16</sup>prudence.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* Financial result driven by investment income (+EUR 435m) and partly offset by insurance finance expenses (-EUR 235m) <sup>p. 16</sup>.
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance.
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>.
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>.
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance <sup>p. 16</sup>.
* Forex impact was unfavorable notably due to USD depreciation vs. EUR <sup>p. 16</sup>.
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 356 ⟶ 343:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP &and other Otherrevenues Revenuesby mixline, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
Line 382 ⟶ 374:
| style="text-align:right" | -7%
|-
| style="text-align:left; font-weight:bold" | Total LifeHealth GWP & Other Revenues
| style="text-align:right; font-weight:bold" | 3417.5
| style="text-align:right; font-weight:bold" | 3719.50
| style="text-align:right; font-weight:bold" | +95%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & Other Revenues mix, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Individual
Line 407 ⟶ 389:
| style="text-align:right" | +4%
|-
| style="text-align:left; font-weight:bold" | TotalEmployee HealthBenefits GWP & Other Revenues
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right; font-weight:bold" | 1912.09
| style="text-align:right; font-weight:bold" | +54%
|}
</div>
Line 416 ⟶ 398:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Net flowsFY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | +2.7
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | +1.5
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
* Employee Benefits GWP and other revenues (including both short-term and long-term) was EUR 12.9bn (+4% vs. FY24) <sup>p. 17</sup>
* Net flows reached +EUR 5.4bn (vs. +EUR 1.5bn in FY24) <sup>p. 17</sup>
 
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
Line 443 ⟶ 433:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP trend by segment, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
Line 468 ⟶ 463:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|}
</div>
Line 478 ⟶ 468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM (pre-tax) and NBV (post-tax), FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | NB CSM (pre-tax)FY24
! class="col-s" style="text-align:right" | NBV (post-tax)FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | FY24NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
|-
| style="text-align:left" | FY25
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
|-
| style="text-align:left" | LFL Change
| style="text-align:right" | +3%
| style="text-align:right" | stable
|}
</div>
 
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
<div style="overflow-x:auto">
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
{| class="wikitable fintable"
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
|+ NBV margin, FY24 vs FY25 <sup>p. 18</sup>
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
! style="text-align:left" | —
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
|}
</div>
* PVEP impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>
* NB CSM driven by robust Savings & Protection sales; reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>
* NBV broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 519 ⟶ 497:
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | CSMValue
|-
| style="text-align:left" | FY24
Line 547 ⟶ 525:
</div>
 
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
<div style="overflow-x:auto">
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
{| class="wikitable fintable"
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
|+ Contractual Service Margin by segment <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
! style="text-align:left" | EUR billion
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Life segment
| style="text-align:right" | 25.8
| style="text-align:right" | 25.4
|-
| style="text-align:left" | Health segment
| style="text-align:right" | 7.7
| style="text-align:right" | 7.6
|}
</div>
 
* '''Normalized CSM''' up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>.
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>.
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>.
* '''FX impact''' mainly from JPY and HKD depreciation <sup>p. 19</sup>.
* '''Normalized CSM growth''' +2% (comprising New business CSM, Underlying return on in-force, and CSM release) <sup>p. 19</sup>
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 575 ⟶ 536:
{| class="wikitable fintable"
|+ Underlying earnings bridge, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 593 ⟶ 554:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
<div style="overflow-x:auto">
* ''Short-term technical margin'': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>
{| class="wikitable fintable"
* ''Long-term result'' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>
|+ Underlying earnings components <sup>p. 20</sup>
* ''Financial result'': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
* ''Tax & others'': EUR -748m in FY24 to EUR -728m in FY25 <sup>p. 20</sup>
! class="col-s" style="text-align:right" | FY24
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup>
! class="col-s" style="text-align:right" | FY25
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup>
|-
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
| style="text-align:left" | Short-term technical margin
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
| style="text-align:right" | 415
| style="text-align:right" | 479
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | 2,680
| style="text-align:right" | 2,804
|-
| style="text-align:left" | Financial result
| style="text-align:right" | 975
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax & others
| style="text-align:right" | -748
| style="text-align:right" | -728
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings by segment <sup>p. 20</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Life
| style="text-align:right" | 2.6
| style="text-align:right" | 2.7
| style="text-align:right" | +4%
|-
| style="text-align:left" | Health
| style="text-align:right" | 0.7
| style="text-align:right" | 0.8
| style="text-align:right" | +17%
|}
</div>
 
* '''Underlying earnings''' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* Strong '''short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico of -EUR 0.1bn <sup>p. 20</sup>
* Higher '''long-term results''' from increase in CSM release of +8% reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 651 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Earnings and net income breakdown inFY24 EURvs billionFY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 677 ⟶ 599:
| style="text-align:right" | -
|-
| style="text-align:left" | ''Underlying earnings''
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
Line 697 ⟶ 619:
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
Line 706 ⟶ 628:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share (reportedbridge, basis)FY24 to FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | FY24Underlying earnings per share
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings per shareFY24
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share change drivers <sup>p. 21</sup>
! style="text-align:left" | Driver
! class="col-s" style="text-align:right" | Contribution
|-
| style="text-align:left" | Earnings growth
Line 734 ⟶ 644:
| style="text-align:right" | -2%
|-
| style="text-align:left" | Temporary earnings dilution from AXA IM sale impact
| style="text-align:right" | -1%
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.86
|}
</div>
 
* '''Underlying earnings''' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* '''Net income''' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
 
=== Shareholders' equity ===
 
* (stacked bar) ''Shareholders' equity'' Group share:
<div style="overflow-x:auto">
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
{| class="wikitable fintable"
|+** Shareholders''HY25'': equityEUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and otherNet OCI EUR metrics-7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY24
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | HY25
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Shareholders' equity (Group share) total
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHE (excl. OCI)
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity roll-forward (in Euro billion) <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | '''Opening Shareholders' equity'''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 831 ⟶ 714:
| style="text-align:right" | 0.3
|-
| style="text-align:left" | '''Closing Shareholders' equity'''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
* '''Reporting currency''' is in Euro billion <sup>p. 22</sup>.
 
=== Higher organic cash remittance and robust cash position at Holding ===
 
* '(bar) ''Net cash remittance''' increased to EUR 7.5bn in FY25 <sup>p. 23</sup>trend:
** (bar) '''Net cash remittance trend'FY24'': FY24 EUR 7.7bn (total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe) → FY25 EUR 7.5bn <sup>p. 23</sup>
** '''Remittance ratio'FY25'': remainedEUR stable7.5bn at 82% in FY24 and 82% in FY25total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge FY24 to FY25 (in Euro billion) <sup>p. 23</sup>
! style="text-align:left" | FY24EUR Cash positionbillion
! class="col-s" style="text-align:right" | 4.0
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
Line 871 ⟶ 757:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | ''FY25 Cash position''
| style="text-align:right" | 5.6
|}
Line 928 ⟶ 814:
</div>
 
* Foreseeable dividends accounted for -EUR 4.8bn.
* Dividend & annual share buyback includes foreseeable dividends of -EUR 4.8bn and provision for annual share buyback for 2026 of -EUR 1.25bn <sup>p. 24</sup>.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities of Solvency II ratio as of December 31, 2025 (base 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 951 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl.excluding PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 968 ⟶ 855:
</div>
 
* Euro sovereign spreads sensitivity assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve, applied on sovereign and quasi-sovereign exposures.
* Solvency II ratio increased to 224% in FY25 from 216% in FY24 <sup>p. 24</sup>.
* EuroCredit sovereignrating spreadsmigration sensitivity assumes a 50bps spread widening20% of the Euro sovereigncorporate bonds vs. the(including Europrivate swapdebt) curve,held appliedare ondowngraded sovereignby andone quasi-sovereignfull exposuresletter <sup>p.(3 24</sup>notches).
* Credit rating migration sensitivity assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) <sup>p. 24</sup>.
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 977 ⟶ 863:
{| class="wikitable fintable"
|+ Solvency II ratio impacts <sup>p. 25</sup>
! style="text-align:left" | Solvency II ratioEvent
! class="col-ms" style="text-align:right" | ValueImpact (pts)
|-
| style="text-align:left" | AsSolvency II ratio as of December 31, 2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10pts to 215%10
|-
| style="text-align:left" | Solvency II revision impact to come into effect in 1Q27
| style="text-align:right" | +17pts17
|}
</div>
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>.
* No change is expected in organic capital generation.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
* Provides additional capital flexibility.
* No change is expected in organic capital generation <sup>p. 25</sup>.
* Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* Provides additional capital flexibility <sup>p. 25</sup>.
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* '''Conclusion'Section divider'' presentedfor the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
 
=== Conclusion ===
 
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''BusinessAll performancebusinesses''' shows all businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''' is well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''FutureLaying outlookfoundations''' focused on laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* '''SessionQ&A titlesession''': Q&Afor the Full Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
* '''Date''': February 26, 2026 <sup>p. 28</sup>
 
=== AXA Investor Relations | Keep in touch ===
 
* '''Investor Relations contact''': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''': www.axa.com <sup>p. 29</sup>
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ Meet our management event calendarschedule <sup>p. 29</sup>
! style="text-align:left" | Date
! class="col-m" style="text-align:right" | Event
Line 1,052 ⟶ 938:
== Appendices ==
 
* Section divider slide for the '''Appendices''' <sup>p. 30</sup>.
 
=== Table of contents ===
 
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* '''Additional P&C disclosures''' <sup>p. 36</sup>
* '''Additional IFRS17 disclosures''' <sup>p. 41</sup>
* '''Sustainability''' <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
 
<div style="overflow-x:auto">
* (stacked bar) '''Gross financial debt''':
{| class="wikitable fintable"
** '''FY24''': EUR 19.2bn total; Tier 1 EUR 4.8bn, Tier 2 EUR 10.8bn, Senior debt EUR 3.5bn; debt gearing at 20.6% <sup>p. 32</sup>
|+ Gross financial debt <sup>p. 32</sup>
** '''FY25''': EUR 20.3bn total; Tier 1 EUR 4.6bn, Tier 2 EUR 12.2bn, Senior debt EUR 3.5bn; debt gearing at 22.3% <sup>p. 32</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total; Tier 1 EUR 3.2bn, Tier 2 EUR 11.3bn, Senior debt EUR 5.8bn (of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
! class="col-s" style="text-align:right" | FY24
* (stacked bar) '''Contractual maturity breakdown''':
! class="col-s" style="text-align:right" | FY25
** '''2028''': Senior debt EUR 0.5bn <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Jan 1st 2026
** '''2030''': Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn <sup>p. 32</sup>
|-
** '''2031-2039''': Senior debt EUR 1.5bn <sup>p. 32</sup>
| style="text-align:left" | Tier 1
** '''≥2040''': Tier 2 EUR 10.8bn, Senior debt EUR 0.5bn <sup>p. 32</sup>
| style="text-align:right" | 4.8
** '''Undated''': Tier 1 EUR 4.6bn, Tier 2 EUR 0.7bn <sup>p. 32</sup>
| style="text-align:right" | 4.6
** '''Of which grandfathered debt''': Tier 1 Undated EUR 1.4bn; Tier 2 2030 EUR 0.7bn, ≥2040 EUR 0.2bn <sup>p. 32</sup>
| style="text-align:right" | 3.2
* (stacked bar) '''Economic maturity breakdown''':
|-
** '''2026''': Tier 1 EUR 0.1bn <sup>p. 32</sup>
| style="text-align:left" | Tier 2
** '''2027''': Tier 2 EUR 2.4bn <sup>p. 32</sup>
| style="text-align:right" | 10.8
** '''2028''': Tier 1 EUR 0.1bn, Senior debt EUR 0.5bn <sup>p. 32</sup>
| style="text-align:right" | 12.2
** '''2029''': Tier 2 EUR 2.0bn <sup>p. 32</sup>
| style="text-align:right" | 11.3
** '''2030''': Tier 2 EUR 0.7bn, Senior debt EUR 0.9bn <sup>p. 32</sup>
|-
** '''2031-2039''': Tier 1 EUR 0.4bn, Tier 2 EUR 6.4bn, Senior debt EUR 1.5bn <sup>p. 32</sup>
**| '''≥2040'''style="text-align:left" | Senior debt EUR 0.5bn <sup>p. 32</sup>
| style="text-align:right" | 3.5
** '''Undated''': Tier 1 EUR 4.0bn, Tier 2 EUR 0.7bn <sup>p. 32</sup>
| style="text-align:right" | 3.5
** '''Of which grandfathered debt''': Tier 1 2026 EUR 0.1bn, 2028 EUR 0.1bn, 2031-2039 EUR 0.4bn, Undated EUR 0.8bn; Tier 2 2030 EUR 0.7bn, ≥2040 EUR 0.2bn <sup>p. 32</sup>
| style="text-align:right" | 5.8
* '''Debt redemptions''' called in January 2026: remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014, and T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
|-
* '''Economic maturity''' accounts for the first date of step-up calls on institutionally placed subordinated debt; Solvency II RT1 debt with no step-up retains its undated nature <sup>p. 32</sup>
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 19.2
| style="text-align:right; font-weight:bold" | 20.3
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2028
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | 10.8
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (contractual)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Economic maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | 2027
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" | 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Grandfathered debt (economic)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2026
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2028
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
 
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
 
=== General account invested assets ===
 
* '''Total General Account''' invested assets stood at EUR 450bn for FY25 <sup>p. 33</sup>.
* '''Duration gap''' was at -0.4 year <sup>p. 33</sup>.
* (donut) '''FY25 Total General Account invested assets''': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans — shares not labeled <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets (100%)breakdown in EUR billionFY25 <sup>p. 33</sup>
! style="text-align:left" | Invested assets (100%) In EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | '''Fixed income'''
| style="text-align:right" | 345
| style="text-align:right" | 77%
Line 1,112 ⟶ 1,156:
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income¹''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | '''Infrastructure equity'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | '''Listed equities²'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | '''Private equity and hedge funds³'''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | '''Cash'''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets⁴'Assets''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
|}
</div>
 
* '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* '''Listed equities''' includes hedges; listed equities excluding hedges stood at EUR 14bn <sup>p. 33</sup>.
* '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
 
=== Structured and private credit assets ===
 
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and Privateprivate Creditcredit assets breakdown FY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) Inin EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
Line 1,183 ⟶ 1,225:
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
Line 1,190 ⟶ 1,232:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | '''69'''
| style="text-align:right" | '''15%'''
| style="text-align:right" | o/w 54% participating
|}
</div>
 
* '''General Account''' (G/A) refersrepresents tothe Generalinvestment Accountportfolio <sup>p. 34</sup>.
 
=== Investment portfolio | Fixed income reinvestment ===
Line 1,203 ⟶ 1,245:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed incomeIncome reinvestmentReinvestment asset mix <sup>p. 35</sup>
! style="text-align:left" | Asset mix
! class="col-s" style="text-align:right" | Share
Line 1,223 ⟶ 1,265:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed incomeIncome reinvestmentReinvestment yieldYield <sup>p. 35</sup>
! style="text-align:left" | Fixed incomeIncome typeType
! class="col-s" style="text-align:right" | Yield
|-
Line 1,237 ⟶ 1,279:
|}
</div>
 
* Fixed income reinvestment totaled EUR 57bn in FY25
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Government bonds & related: average rating: AA
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
* Investment grade credit: average rating: A
** Average duration of 9 years <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn invested
** Private & Structured Credit reinvestment of EUR 19.7bn at 4.7% yield, including CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY <sup>p. 35</sup>
* Average duration of 9 years
** Strategic shift characterized by a gradual transition from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (comprising CLOs, ABS, Infra & CRE debt, Fund financing and Private HY)
* Asset allocation reflects a gradual shift from alternative total return assets to Private & Structured credit
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,251 ⟶ 1,297:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP breakdownby line of business <sup>p. 37</sup>
! style="text-align:left" | USDLine billionof unless otherwise mentionedbusiness
! class="col-s" style="text-align:right" | Share
|-
Line 1,272 ⟶ 1,318:
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | USD billionGeography
! class="col-s" style="text-align:right" | Share
|-
Line 1,286 ⟶ 1,332:
</div>
 
<div style="overflow-x:auto">
* '''Business diversification''' is well balanced across lines of business and geographies <sup>p. 37</sup>
{| class="wikitable"
* '''Market leadership''' positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
|+ Profitability vs Ex-price growth (%) <sup>p. 37</sup>
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
 
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* '''Cycle management''' is utilized to deliver consistent profitability <sup>p. 37</sup>:
** (bubble chart) '''Profitability vs Ex-price growth (%)'Property'': showshigh relativeprofitability, positioninghigh ofex-price key linesgrowth <sup>p. 37</sup>:
*** '''Property'Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
*** '''Specialty'Casualty'': moderate-to-highmedium profitability, moderatemedium ex-price growth <sup>p. 37</sup>
*** '''Casualty'Professional lines'': moderatelower profitability, moderatelower ex-price growth <sup>p. 37</sup>
*** '''Professional lines''': lower profitability, lower ex-price growth <sup>p. 37</sup>
 
=== P&C | Focus on reserves ===
Line 1,302 ⟶ 1,372:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and Technicaltechnical reserves ratioratios <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18
Line 1,354 ⟶ 1,424:
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
* ¹ Includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection capacity and retention by peril <sup>p. 39</sup>
! style="text-align:left" | PerilEUR
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" | EU Windstorm
| class="col-s" style="text-align:right" | EUR 4.0bn600m
| class="col-s" style="text-align:right" | EUR 600m4.0bn
|-
| style="text-align:left" | Europe Flood
| class="col-s" style="text-align:right" | EUR 2.1bn450m
| class="col-s" style="text-align:right" | EUR 450m2.1bn
|-
| style="text-align:left" | Europe Earthquake
| class="col-s" style="text-align:right" | EUR 2.1bn400m
| class="col-s" style="text-align:right" | EUR 400m2.1bn
|-
| style="text-align:left" | NA Hurricane
| class="col-s" style="text-align:right" | EUR 1.2bn600m
| class="col-s" style="text-align:right" | EUR 600m1.2bn
|-
| style="text-align:left" | NA Earthquake
| class="col-s" style="text-align:right" | EUR 1.2bn600m
| class="col-s" style="text-align:right" | EUR 600m1.2bn
|-
| style="text-align:left" | Per other perils
| class="col-s" style="text-align:right" | 400m
| class="col-s" style="text-align:right" | EURVaries by peril 400mtype
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
 
* (diagram) ''Reinsurance segment'' (illustrative):
* '''Retention levels''' remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram)Covered '''Reinsurancevia segment''' (illustrative) utilizes Alternative Capital & Cat Bonds'' <sup>p. 39</sup>.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
Line 1,399 ⟶ 1,468:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup>
! style="text-align:left" | PercentileReturn period / probability percentile
! class="col-s" style="text-align:right" | EUR billion
|-
Line 1,431 ⟶ 1,500:
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | EUR billion
! class="col-s" style="text-align:right" | ImpactEstimated impact on GEP
|-
| style="text-align:left" | 2025
Line 1,442 ⟶ 1,511:
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
 
* '''EarningsLess deviationsevere analysis'years'' showsresult Groupin underlyinga earningspositive deviation to average Nat Cat charges in 2026ca. net60% of reinsurance, post-taxcases <sup>p. 40</sup>:.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
** '''More severe years''' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
** '''Less severe years''' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* '''Natural catastrophe cost''' is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* '''Deviation comparison''' is made against a normalized level, which represents costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) <sup>p. 40</sup>.
 
=== Table of contents ===
 
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* '''Additional P&C disclosures''' <sup>p. 36</sup>
* '''Additional IFRS17 disclosures''' (active section) <sup>p. 41</sup>
* '''Sustainability''' <sup>p. 44</sup>
 
=== P&C | Margin analysis ===
Line 1,460 ⟶ 1,526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C Underlyingmargin Earningsanalysis FY25and (changesunderlying versusearnings FY24 at constant FX)FY25 <sup>p. 42</sup>
! style="text-align:left" | MetricEUR million
! class="col-s" style="text-align:right" | FY25 (EUR million)
! class="col-s" style="text-align:right" | Change (EUR million)
|-
| style="text-align:left" | ''Current Accident Year Undiscounted Technical Margin''
| style="text-align:right" | 2,778
| style="text-align:right" | +707
|-
| style="text-align:left" | ''Current Accident Year Discounting''
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | ''Prior Years' Reserve Development (PYD)''
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" | ''Investment Income''
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | ''Insurance Finance Expenses''
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 1,477 ⟶ 1,563:
| style="text-align:right" | -10
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | '''5,872'''
| style="text-align:right" | '''+501'''
|-
| style="text-align:left" | ''Growth vs. FY24 (at constant FX)''
| style="text-align:right" | —
| style="text-align:right" | ''+9%''
|}
</div>
 
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
Caption: Technical result components (pre-tax, changes versus FY24 at
* '''Undiscounted technicalcombined margin'ratio'' (current95.2% accident year(-1.0pt); of EURwhich 2,778mNat (+EURCats 707mwas 3.4% (-0.4pt) <sup>p. 42</sup>:
* '''Gross earnedDiscounting premiums'ratio'' at-3.5% EUR(+0.0pt 57,656min (+6%Combined Ratio points) <sup>p. 42</sup>
* '''UndiscountedNet combinedclaims ratio'reserves'' (for current accident year) at 95.2%EUR (-119.0pt),0bn; duration of which4.0 Natyears; Catsdiscount wasrate 3of 2.48% (-0.4pt) <sup>p. 42</sup>
* '''Accident yearPYD discounting'ratio'' (current accident year) of EUR 2,009m-1.1% (+EUR 115m0.7pt) <sup>p. 42</sup>:
* '''DiscountingAverage ratio'assets'' (infor combinedFY25 ratioat points)EUR 115bn; asset book yield at -3.5%; (+0reinvestment yield on fixed income assets at 4.0pt)3% <sup>p. 42</sup>
* '''NetReserves claimsat locked-in reserves'rate'' (currentfor accident year)FY24 at EUR 1971bn; liability book yield at 1.0bn9% <sup>p. 42</sup>
* '''ReserveUnderlying earnings duration'growth'' at+9% 4vs.0 yearsFY24 withat aconstant discount rate of 2.8%FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
* '''Reserve development''' (prior years' PYD) of EUR 622m (-EUR 341m) with a PYD ratio of -1.1% (+0.7pt) <sup>p. 42</sup>
** '''Investment+25bps: income''' of EUR 3,988m (+EUR 435m)0.2bn <sup>p. 42</sup>:
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* '''Average assets''' (FY25) at EUR 115bn with an asset book yield of 3.5% and reinvestment yield on fixed income assets of 4.3% <sup>p. 42</sup>
* '''Insurance finance expenses''': of2026e pre-EURtax 1,358mexpected (-at ~EUR 235m)-1.4bn <sup>p. 42</sup>:
** '''ReservesSensitivity atof locked-in2026e rate'''expenses (FY24)to atchanges EURin 71bn2025 withcurrent aAY liabilitydiscount: book+25bps yield~EUR of-50m; -25bps ~EUR 1.9%+50m <sup>p. 42</sup>
* '''Rate increase''' of +25bps: +EUR 0.2bn <sup>p. 42</sup>
* '''Rate decrease''' of -25bps: -EUR 0.2bn <sup>p. 42</sup>
* '''Future finance expenses''' projected for 2026e (pre-tax) at ~ -EUR 1.4bn <sup>p. 42</sup>:
* '''Sensitivity to discount changes''' (+25bps in 2025 current AY discount): ~ -EUR 50m <sup>p. 42</sup>
* '''Sensitivity to discount changes''' (-25bps in 2025 current AY discount): ~ +EUR 50m <sup>p. 42</sup>
 
=== L&H | Margin analysis ===
 
* '''L&H Marginmargin Analysis'analysis'' includes scope impact <sup>p. 43</sup>.
* '''Short-term Technicaltechnical Margin'margin'' includes+EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical Resultand (Infinancial results in Euro million, pre-tax) <sup>p. 43</sup>
! style="text-align:left" | MetricTechnical and Financial Results
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
Line 1,521 ⟶ 1,607:
| style="text-align:right" | 479
| style="text-align:right" | +60
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
|-
| style="text-align:left" | All Year Combined Ratio
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pts
|-
| style="text-align:left" | Long-term Technical Margin
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|-
| style="text-align:left" | CSM release
| style="text-align:right" | 2,954
| style="text-align:right" | +215
|-
| style="text-align:left" | Technical experience
| style="text-align:right" | -150
| style="text-align:right" | -58
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Financial Result (In Euro million, pre-tax) <sup>p. 43</sup>
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Investment Income (non-VFA only)
Line 1,560 ⟶ 1,621:
|}
</div>
 
* '''Investment Income details (non-VFA only)''':
** '''FY25 Average Assets''': EUR 98bn <sup>p. 43</sup>
** '''Asset book yield''': 2.5% <sup>p. 43</sup>
** '''FY25 Reinvestment yield¹''': 3.8% <sup>p. 43</sup>
* '''Insurance Finance Expenses details (non-VFA only)''':
** '''FY24 Reserves at locked-in rate''': EUR 62bn <sup>p. 43</sup>
** '''Liability book yield''': 2.5% <sup>p. 43</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earningsearnings (Inbridge in Euro million) <sup>p. 43</sup>
! style="text-align:left" | MetricUnderlying Earnings
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
Line 1,594 ⟶ 1,647:
</div>
 
* '''Underlying Earningsearnings growth''' vs.+7% versus FY24 (at constant FX): +7% <sup>p. 43</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Keykey Sensitivitiessensitivities (in Euro billion) <sup>p. 43</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | ValueImpact
|-
| style="text-align:left" | Baseline
Line 1,630 ⟶ 1,683:
|}
</div>
 
* ¹ Reinvestment yield on fixed income assets <sup>p. 43</sup>.
 
=== Table of contents ===
 
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
 
<div style="overflow-x:auto">
* '''As a Global Investor''':
{| class="wikitable"
** '''Climate transition financing''': Target of EUR 5bn per year in climate transition financing <sup>p. 45</sup>; 2025 Result achieved EUR 6.4bn <sup>p. 45</sup>.
|+ ESG targets and achievements <sup>p. 45</sup>
** '''Community resilience financing''': Target of >EUR 500m per year <sup>p. 45</sup>; 2025 Result achieved EUR 1.4bn <sup>p. 45</sup>.
! style="text-align:left" | Category
* '''As a Global Insurer''':
! class="col-m" style="text-align:right" | Target
** '''Transition underwriting''': Target of EUR 6bn in P&C GWP to support transition underwriting (cumulative 2024-2026) <sup>p. 45</sup>; 2025 Result achieved EUR 4.6bn <sup>p. 45</sup>.
! class="col-m" style="text-align:right" | Achieved in 2025
** '''Climate adaptation solutions''': Target of >20,000 climate adaptation solutions & services (cumulative 2024-2026, target revised in 2025) <sup>p. 45</sup>; 2025 Result achieved 19,698 cumulative 2024-2025 <sup>p. 45</sup>.
|-
** '''Inclusive insurance''': Target of >20m inclusive insurance customers by 2026 <sup>p. 45</sup>; 2025 Result achieved 20.6m <sup>p. 45</sup>.
| style="text-align:left" | Climate transition financing
* '''As a Company''':
| class="col-m" style="text-align:right" | EUR 5bn per year
** '''Climate adaptation training''': Target of >80,000 AXA Group employees trained on climate adaptation by 2026 <sup>p. 45</sup>; 2025 Result achieved 46,420 <sup>p. 45</sup>.
| class="col-m" style="text-align:right" | EUR 6.4bn
** '''Carbon emissions reduction''': Target to contribute to Net-Zero with -50% by 2030 in absolute carbon emissions and offset of residual emissions <sup>p. 45</sup>; 2025 Result achieved -64% reduction against 2019 <sup>p. 45</sup>.
|-
** '''Employee volunteering''': Target of 50% of AXA Group employees engaged in volunteering activities by 2026 <sup>p. 45</sup>; 2025 Result achieved 56% <sup>p. 45</sup>.
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | Transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | Climate adaptation training
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Carbon emissions reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% against 2019
|-
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
 
=== Sustainability Performance & Ratings ===
Line 1,653 ⟶ 1,738:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG ratings and scores, 2025 <sup>p. 46</sup>
! style="text-align:left" | Rating agencyAgency
! class="col-ls" style="text-align:right" | Score/Percentile
|-
| style="text-align:left" | S&P Global percentile
| class="col-ls" style="text-align:right" | 97th percentile
|-
| style="text-align:left" | MSCI
| class="col-ls" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-ls" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-ls" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-ls" style="text-align:right" | 4.3/5
|}
</div>
 
* '''S&P Global''' 2025 percentile: 97th in Dow Jones Best-in-Class Europe & World indices <sup>p. 46</sup>; the CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* '''FTSE Russell''' 2025 score: 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
 
=== Scope ===
 
* '''France''' scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''' scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''' scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''' scope includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated; and China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings, and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are fully consolidated;, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''' scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* '''Accounting standards''': Unless otherwise specified, all comparative figures going back to 2023 are under IFRS17/9 standards (effective January 1, 2023); figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>
* '''Contractual Service Margin (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>
* '''Technical experience''': consists of the impacts on the underlying earnings ifof (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
 
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* Concluding''Closing slide'' offor the AXA Full Year 2025 Earnings presentation, dated February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''AA''': S&P long-term issuerSenior creditbond rating
* '''AAA''': S&P long-term issuerSenior creditbond rating
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* ''AMF'': Autorité des marchés financiers
* '''APAC''': Asia-Pacific
* '''AXA IM'APAC'': AXA Investment ManagersAsia-Pacific
* ''AXA IM'': AXA Investment Managers
* '''AXA XL''': AXA XL (AXA's commercial property and casualty and specialty risk division)
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* '''AY''': Accident Year
* '''BBA'AY'': Business-By-BusinessAccident AccountingYear
* '''CDP'BBA'': Carbon DisclosureBenefit-Bearing ProjectAccount
* '''CLO'CDP'': CollateralizedCarbon LoanDisclosure ObligationProject
* '''CRE'CLO'': CommercialCollateralized RealLoan EstateObligation
* '''CSA'CRE'': CorporateCommercial SustainabilityReal AssessmentEstate
* ''CSA'': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY'CSM'': CalendarContractual Service YearMargin
* '''EME'CY'': EmergingCalendar MarketsYear
* '''EOF'DPS'': EligibleDividend OwnPer FundsShare
* '''EPS'EME'': Earnings PerEmerging ShareMarkets
* ''EOF'': Eligible Own Funds
* '''ESG''': Environmental, Social, and Governance
* '''EU'EPS'': EuropeanEarnings Per UnionShare
* ''ESG'': Environmental, Social, and Governance
* '''FX''': Foreign Exchange
* ''ESMA'': European Securities and Markets Authority
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP'EU'': Gross EarnedEuropean PremiumUnion
* '''GF EUR''': Grandfathered Euro
* ''FX'': Foreign Exchange
* '''GF GBP''': Grandfathered British Pound
* ''GAAP'': Generally Accepted Accounting Principles
* '''GWP''': Gross Written Premiums
* '''HKD'GBP'': HongGreat KongBritish DollarPound
* '''HY'GEP'': HighGross Earned YieldPremium
* '''IFE'GWP'': InsuranceGross FinanceWritten ExpensesPremiums
* ''HKD'': Hong Kong Dollar
* '''IFRS''': International Financial Reporting Standards
* '''IG'HY'': InvestmentHigh GradeYield
* '''JPY'IFE'': JapaneseInsurance Finance YenExpenses
* ''IFRS'': International Financial Reporting Standards
* '''LATAM''': Latin America
* '''LFL'IG'': Like-for-LikeInvestment Grade
* '''LTV'JPY'': Loan-to-ValueJapanese Yen
* ''LATAM'': Latin America
* '''MSCI''': Morgan Stanley Capital International
* '''NA'LFL'': North AmericaLike-for-Like
* ''LTV'': Loan-to-Value
* '''NB CSM''': New Business Contractual Service Margin
* ''MSCI'': Morgan Stanley Capital International
* '''NBV''': New Business Value
* '''NHG'NA'': Nationale HypotheekNorth GarantieAmerica
* ''NB CSM'': New Business Contractual Service Margin
* '''NPS''': Net Promoter Score
* '''OCI'NBV'': OtherNew ComprehensiveBusiness IncomeValue
* '''PAA'NHG'': PremiumNationale AllocationHypotheek ApproachGarantie
* '''PE'NPS'': PrivateNet Promoter EquityScore
* ''OCI'': Other Comprehensive Income
* '''PVEP''': Present Value of Expected Profits
* '''PYD'PAA'': PriorParticipating YearAccount DevelopmentAgreement
* ''PE'': Private Equity
* '''RCG''': Reinsurance Commission and General expenses
* '''ROE'PVEP'': ReturnPresent Value of onExpected EquityProfits
* '''SCR'PYD'': SolvencyPrior Years' CapitalReserve RequirementDevelopment
* '''SHE'RCG'': Shareholders'Reinsurance Capital EquityGeneration
* '''SME'ROE'': Small andReturn Medium-sizedon EnterprisesEquity
* ''SCR'': Solvency Capital Requirement
* '''TVOG''': Time Value of Options and Guarantees
* '''UEPS'SHE'': Underlying Earnings PerShareholders' ShareEquity
* ''SME'': Small and Medium-sized Enterprises
* '''UK''': United Kingdom
* ''TVOG'': Time Value of Options and Guarantees
* '''US''': United States
* '''USD'UEPS'': UnitedUnderlying Earnings StatesPer DollarShare
* '''VAT'UK'': Value AddedUnited TaxKingdom
* '''VFA'US'': Variable FeeUnited ApproachStates
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach